311 related articles for article (PubMed ID: 19956155)
1. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman M; Stockton D; Rachet B; Hakulinen T; Coleman MP
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S115-24. PubMed ID: 19956155
[TBL] [Abstract][Full Text] [Related]
2. How many deaths have been avoided through improvements in cancer survival?
Richards MA; Stockton D; Babb P; Coleman MP
BMJ; 2000 Apr; 320(7239):895-8. PubMed ID: 10741993
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. How many cancer deaths could New Zealand avoid if five-year relative survival ratios were the same as in Australia?
Sandiford P; Abdel-Rahman ME; Allemani C; Coleman MP; Gala G
Aust N Z J Public Health; 2015 Apr; 39(2):157-61. PubMed ID: 25716332
[TBL] [Abstract][Full Text] [Related]
5. How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006.
Ellis L; Coleman MP; Rachet B
Eur J Cancer; 2012 Jan; 48(2):270-8. PubMed ID: 22093945
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic inequalities in cancer survival in England and Wales.
Coleman MP; Babb P; Sloggett A; Quinn M; De Stavola B
Cancer; 2001 Jan; 91(1 Suppl):208-16. PubMed ID: 11148581
[TBL] [Abstract][Full Text] [Related]
7. Estimates of cancer incidence and mortality in Europe in 1995.
Bray F; Sankila R; Ferlay J; Parkin DM
Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
[TBL] [Abstract][Full Text] [Related]
8. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
[TBL] [Abstract][Full Text] [Related]
9. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
[TBL] [Abstract][Full Text] [Related]
10. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
Berrino F; De Angelis R; Sant M; Rosso S; Bielska-Lasota M; Coebergh JW; Santaquilani M;
Lancet Oncol; 2007 Sep; 8(9):773-83. PubMed ID: 17714991
[TBL] [Abstract][Full Text] [Related]
11. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
12. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.
Boyle P
Lung Cancer; 1997 May; 17(1):1-60. PubMed ID: 9194026
[TBL] [Abstract][Full Text] [Related]
13. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
Malvezzi M; Bertuccio P; Rosso T; Rota M; Levi F; La Vecchia C; Negri E
Ann Oncol; 2015 Apr; 26(4):779-786. PubMed ID: 25623049
[TBL] [Abstract][Full Text] [Related]
14. Avoidable Mortality: The Core of the Global Cancer Divide.
Knaul FM; Arreola-Ornelas H; Rodriguez NM; Méndez-Carniado O; Kwete XJ; Puentes-Rosas E; Bhadelia A
J Glob Oncol; 2018 Jul; 4():1-12. PubMed ID: 30096010
[TBL] [Abstract][Full Text] [Related]
15. Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries.
Dickman PW; Gibberd RW; Hakulinen T
J Epidemiol Community Health; 1997 Jun; 51(3):289-98. PubMed ID: 9229059
[TBL] [Abstract][Full Text] [Related]
16. Cancer mortality in migrants from the British Isles and continental Europe to New South Wales, Australia, 1975-1995.
McCredie M; Williams S; Coates M
Int J Cancer; 1999 Oct; 83(2):179-85. PubMed ID: 10471524
[TBL] [Abstract][Full Text] [Related]
17. Increasing inequalities in premature mortality in Great Britain.
Leyland AH
J Epidemiol Community Health; 2004 Apr; 58(4):296-302. PubMed ID: 15026442
[TBL] [Abstract][Full Text] [Related]
18. Cancer mortality in Europe in 2015 and an overview of trends since 1990.
Bertuccio P; Alicandro G; Malvezzi M; Carioli G; Boffetta P; Levi F; La Vecchia C; Negri E
Ann Oncol; 2019 Aug; 30(8):1356-1369. PubMed ID: 31147719
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany.
Jansen L; Kanbach J; Finke I; Arndt V; Emrich K; Holleczek B; Kajüter H; Kieschke J; Maier W; Pritzkuleit R; Sirri E; Schwettmann L; Erb C; Brenner H; Group FTGCSW
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33478065
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
Ferlay J; Steliarova-Foucher E; Lortet-Tieulent J; Rosso S; Coebergh JW; Comber H; Forman D; Bray F
Eur J Cancer; 2013 Apr; 49(6):1374-403. PubMed ID: 23485231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
